OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of incretin receptor agonists in the treatment of obesity
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4178-4196
Open Access | Times Cited: 4
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4178-4196
Open Access | Times Cited: 4
Showing 4 citing articles:
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Effect of Artemisia selengensis Turcz extract on lipid metabolism and gut microbiota in high‐fat diet‐induced C57BL/6J obese mice
Lu Zhang, Mei Deng, Qing‐Hui Wen, et al.
Journal of Food Science (2025) Vol. 90, Iss. 4
Closed Access
Lu Zhang, Mei Deng, Qing‐Hui Wen, et al.
Journal of Food Science (2025) Vol. 90, Iss. 4
Closed Access
EFICÁCIA COMPARADA ENTRE SEMAGLUTIDA E TIRZEPATIDA PARA TRATAMENTO DE OBESIDADE: UMA REVISÃO DE LITERATURA
Júlia Moreno Turchetto, Gabriela Faria, Emilene Dias Fiuza Ferreira
Revista Foco (2025) Vol. 18, Iss. 3, pp. e8015-e8015
Open Access
Júlia Moreno Turchetto, Gabriela Faria, Emilene Dias Fiuza Ferreira
Revista Foco (2025) Vol. 18, Iss. 3, pp. e8015-e8015
Open Access
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity
Nadine Beetz, Brigitte Kalsch, Thomas Först, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 2
Nadine Beetz, Brigitte Kalsch, Thomas Först, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 2
